Twice-Yearly shot could replace daily HIV prevention pills
NCT ID NCT06101329
First seen Nov 01, 2025 · Last updated May 23, 2026 · Updated 36 times
Summary
This study looks at a new HIV prevention option for cisgender women in the US: a shot given under the skin every 6 months, called lenacapavir. Researchers want to see how the drug behaves in the body, how safe it is, and if women find it acceptable compared to taking a daily pill. About 253 women who have had condomless sex with a man in the past year are taking part.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PRE-EXPOSURE PROPHYLAXIS OF HIV INFECTION are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Cornell Clinical Trials Unit, New York Presbyterian Hospital - Weill Cornell Medicine
New York, New York, 10010, United States
-
Fenway Health
Boston, Massachusetts, 02215, United States
-
George Washington University Medical Faculty Associates
Washington D.C., District of Columbia, 20037, United States
-
Harlem Prevention Center CRS
New York, New York, 10027, United States
-
ICAP at Columbia University - Bronx Prevention Center
The Bronx, New York, 10451, United States
-
NC TraCS Institute - CTRC; University of North Carolina at Chapel Hill
Chapel Hill, North Carolina, 27599, United States
-
Penn Prevention Research Unit
Philadelphia, Pennsylvania, 19104, United States
-
Ponce de Leon Center Clinical Research Site
Atlanta, Georgia, 30303, United States
-
Rutgers New Jesey Medical School - Clinical Research Center
Newark, New Jersey, 07103, United States
-
UAB, 1917 Research Clinic
Birmingham, Alabama, 35222, United States
-
UCSD Antiviral Research Center (AVRC)
San Diego, California, 92103, United States
Conditions
Explore the condition pages connected to this study.